Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and PK/PD of Lanifibranor in Type 2 Diabetes
NCT00924534Phase 2Completed
- Sponsor
- Abbott Laboratories
- Start
- Dec 2009
- Primary completion
- Dec 2010
- Modality
- Small Molecules
- Countries
- 3
01
Overview
A Phase 2 trial of lanifibranor in type 2 diabetes mellitus (T2DM), sponsored by Abbott Laboratories. Started Dec 2009; status: completed.
02
Drugs
lanifibranor
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT00924534.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00924534.